430 related articles for article (PubMed ID: 10629553)
21. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
22. Advances in biology, diagnostics, and treatment of Hodgkin's disease.
Küppers R; Yahalom J; Josting A
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):66-76. PubMed ID: 16399588
[TBL] [Abstract][Full Text] [Related]
23. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease.
Weber-Matthiesen K; Deerberg J; Poetsch M; Grote W; Schlegelberger B
Blood; 1995 Aug; 86(4):1464-8. PubMed ID: 7632954
[TBL] [Abstract][Full Text] [Related]
24. The immunohistochemistry of Hodgkin's disease.
Said JW
Semin Diagn Pathol; 1992 Nov; 9(4):265-71. PubMed ID: 1362283
[TBL] [Abstract][Full Text] [Related]
25. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
[TBL] [Abstract][Full Text] [Related]
26. [Hodgkin's disease: biology can help the physician towards new prognostic factors and new therapeutic approaches].
Rubio MT; Ghesquières H; Blay JY; Salles G
Bull Cancer; 2001 Nov; 88(11):1081-90. PubMed ID: 11741802
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
28. Can Reed-Sternberg cells of classic Hodgkin's disease be considered B-cells?
Carbone A; Gloghini A; Gaidano G
Adv Clin Path; 1999; 3(1-2):3-9. PubMed ID: 10655568
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR).
Heine B; Hummel M; Demel G; Stein H
J Pathol; 1999 Jun; 188(2):139-45. PubMed ID: 10398156
[TBL] [Abstract][Full Text] [Related]
30. Quantitative approach to the immunohistochemical analysis of p53 antioncogene and CD30 antigen in Hodgkin' disease.
Chilosi M; Montagna L; Lestani M; Menestrina F; Mariuzzi GM
In Vivo; 1993; 7(4):393-4. PubMed ID: 8218985
[TBL] [Abstract][Full Text] [Related]
31. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma.
Kadin ME; Drews R; Samel A; Gilchrist A; Kocher O
Hum Pathol; 2001 Nov; 32(11):1269-72. PubMed ID: 11727269
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin.
Kremer M; Sandherr M; Geist B; Cabras AD; Höfler H; Fend F
Mod Pathol; 2001 Feb; 14(2):91-7. PubMed ID: 11235910
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-induced B-cell proliferation of Hodgkin's and Reed-Sternberg cell pheno- and genotype may develop in peripheral T-cell lymphomas.
Pajor L; Kajtár B; Jáksó P; Lacza A; László R; Radványi G; Mórocz I; Tóth A; Varga G
Histopathology; 2006 Nov; 49(5):553-7. PubMed ID: 17064310
[No Abstract] [Full Text] [Related]
35. The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity.
Mathas S
Hematol Oncol Clin North Am; 2007 Oct; 21(5):787-804. PubMed ID: 17908620
[TBL] [Abstract][Full Text] [Related]
36. Implication of the Epstein-Barr virus in the progression of chronic lymphocytic leukaemia/small lymphocytic lymphoma to Hodgkin-like lymphomas.
Petrella T; Yaziji N; Collin F; Rifle G; Morlevat F; Arnould L; Fargeot P; Depret O
Anticancer Res; 1997; 17(5B):3907-13. PubMed ID: 9427802
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of monocytoid B-lymphocytes in Hodgkin's disease.
Ohsawa M; Kanno H; Naka N; Aozasa K
Mod Pathol; 1994 Jun; 7(5):540-3. PubMed ID: 7937719
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
39. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?
Menestrina F; Chilosi M; Scarpa A
Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
